{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:58:30Z","timestamp":1790737110009,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"7607","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1038\/nature17988","type":"journal-article","created":{"date-parts":[[2016,6,3]],"date-time":"2016-06-03T11:18:30Z","timestamp":1464952710000},"page":"407-411","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":132,"title":["Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma"],"prefix":"10.1038","volume":"534","author":[{"given":"Raymond G.","family":"Fox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki K.","family":"Lytle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn V.","family":"Jaquish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick D.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeevisha","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire S.","family":"Koechlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Zimdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janel L.","family":"Kopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcie","family":"Kritzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason K.","family":"Sicklick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Grandgenett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Hollingsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Pizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Valasek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Sasik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Scadeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Okano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngsoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Robert","family":"MacLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Lowy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tannishtha","family":"Reya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,6]]},"reference":[{"key":"BFnature17988_CR1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.5858\/133.3.413","volume":"133","author":"S Yachida","year":"2009","unstructured":"Yachida, S. & Iacobuzio-Donahue, C. A. The pathology and genetics of metastatic pancreatic cancer. Arch. Pathol. Lab. Med. 133, 413\u2013422 (2009).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"BFnature17988_CR2","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/0092-8674(88)90571-5","volume":"53","author":"C Almoguera","year":"1988","unstructured":"Almoguera, C. et al. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53, 549\u2013554 (1988).","journal-title":"Cell"},{"key":"BFnature17988_CR3","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1126\/science.271.5247.350","volume":"271","author":"SA Hahn","year":"1996","unstructured":"Hahn, S. A. et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271, 350\u2013353 (1996).","journal-title":"Science"},{"key":"BFnature17988_CR4","first-page":"3025","volume":"54","author":"MS Redston","year":"1994","unstructured":"Redston, M. S. et al. p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. Cancer Res. 54, 3025\u20133033 (1994).","journal-title":"Cancer Res."},{"key":"BFnature17988_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0896-6273(94)90460-X","volume":"13","author":"M Nakamura","year":"1994","unstructured":"Nakamura, M., Okano, H., Blendy, J. A. & Montell, C. Musashi, a neural RNA-binding protein required for Drosophila adult external sensory organ development. Neuron 13, 67\u201381 (1994).","journal-title":"Neuron"},{"key":"BFnature17988_CR6","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1242\/jcs.115.7.1355","volume":"115","author":"H Okano","year":"2002","unstructured":"Okano, H., Imai, T. & Okabe, M. Musashi: a translational regulator of cell fate. J. Cell Sci. 115, 1355\u20131359 (2002).","journal-title":"J. Cell Sci."},{"key":"BFnature17988_CR7","doi-asserted-by":"publisher","first-page":"15194","DOI":"10.1073\/pnas.232087499","volume":"99","author":"S Sakakibara","year":"2002","unstructured":"Sakakibara, S. et al. RNA-binding protein Musashi family: roles for CNS stem cells and a subpopulation of ependymal cells revealed by targeted disruption and antisense ablation. Proc. Natl Acad. Sci. USA 99, 15194\u201315199 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature17988_CR8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.stem.2010.06.007","volume":"7","author":"KJ Hope","year":"2010","unstructured":"Hope, K. J. et al. An RNAi screen identifies Msi2 and Prox1 as having opposite roles in the regulation of hematopoietic stem cell activity. Cell Stem Cell 7, 101\u2013113 (2010).","journal-title":"Cell Stem Cell"},{"key":"BFnature17988_CR9","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nature09171","volume":"466","author":"T Ito","year":"2010","unstructured":"Ito, T. et al. Regulation of myeloid leukaemia by the cell-fate determinant Musashi. Nature 466, 765\u2013768 (2010).","journal-title":"Nature"},{"key":"BFnature17988_CR10","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/nm.2187","volume":"16","author":"MG Kharas","year":"2010","unstructured":"Kharas, M. G. et al. Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia. Nature Med. 16, 903\u2013908 (2010).","journal-title":"Nature Med."},{"key":"BFnature17988_CR11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.stem.2015.06.006","volume":"17","author":"HY Kwon","year":"2015","unstructured":"Kwon, H. Y. et al. Tetraspanin 3 is required for the development and propagation of acute myelogenous leukemia. Cell Stem Cell 17, 152\u2013164 (2015).","journal-title":"Cell Stem Cell"},{"key":"BFnature17988_CR12","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1182\/blood-2010-12-322081","volume":"118","author":"L de Andr\u00e9s-Aguayo","year":"2011","unstructured":"de Andr\u00e9s-Aguayo, L. et al. Musashi 2 is a regulator of the HSC compartment identified by a retroviral insertion screen and knockout mice. Blood 118, 554\u2013564 (2011).","journal-title":"Blood"},{"key":"BFnature17988_CR13","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S1535-6108(03)00309-X","volume":"4","author":"SR Hingorani","year":"2003","unstructured":"Hingorani, S. R. et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4, 437\u2013450 (2003).","journal-title":"Cancer Cell"},{"key":"BFnature17988_CR14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/ng959","volume":"32","author":"Y Kawaguchi","year":"2002","unstructured":"Kawaguchi, Y. et al. The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors. Nature Genet. 32, 128\u2013134 (2002).","journal-title":"Nature Genet."},{"key":"BFnature17988_CR15","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1535-6108(04)00085-6","volume":"5","author":"DA Tuveson","year":"2004","unstructured":"Tuveson, D. A. et al. Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell 5, 375\u2013387 (2004).","journal-title":"Cancer Cell"},{"key":"BFnature17988_CR16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/35102167","volume":"414","author":"T Reya","year":"2001","unstructured":"Reya, T., Morrison, S. J., Clarke, M. F. & Weissman, I. L. Stem cells, cancer, and cancer stem cells. Nature 414, 105\u2013111 (2001).","journal-title":"Nature"},{"key":"BFnature17988_CR17","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.tcb.2005.07.004","volume":"15","author":"JC Wang","year":"2005","unstructured":"Wang, J. C. & Dick, J. E. Cancer stem cells: lessons from leukemia. Trends Cell Biol. 15, 494\u2013501 (2005).","journal-title":"Trends Cell Biol."},{"key":"BFnature17988_CR18","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.stem.2007.06.002","volume":"1","author":"PC Hermann","year":"2007","unstructured":"Hermann, P. C. et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1, 313\u2013323 (2007).","journal-title":"Cell Stem Cell"},{"key":"BFnature17988_CR19","doi-asserted-by":"publisher","first-page":"e20636","DOI":"10.1371\/journal.pone.0020636","volume":"6","author":"MP Kim","year":"2011","unstructured":"Kim, M. P. et al. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma. PLoS ONE 6, e20636 (2011).","journal-title":"PLoS ONE"},{"key":"BFnature17988_CR20","doi-asserted-by":"publisher","first-page":"4582","DOI":"10.1158\/0008-5472.CAN-14-2793","volume":"75","author":"JS Dosch","year":"2015","unstructured":"Dosch, J. S., Ziemke, E. K., Shettigar, A., Rehemtulla, A. & Sebolt-Leopold, J. S. Cancer stem cell marker phenotypes are reversible and functionally homogeneous in a preclinical model of pancreatic cancer. Cancer Res. 75, 4582\u20134592 (2015).","journal-title":"Cancer Res."},{"key":"BFnature17988_CR21","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cell.2011.11.025","volume":"148","author":"AD Rhim","year":"2012","unstructured":"Rhim, A. D. et al. EMT and dissemination precede pancreatic tumor formation. Cell 148, 349\u2013361 (2012).","journal-title":"Cell"},{"key":"BFnature17988_CR22","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1053\/j.gastro.2011.08.009","volume":"141","author":"C Li","year":"2011","unstructured":"Li, C. et al. c-Met is a marker of pancreatic cancer stem cells and therapeutic target. Gastroenterology 141, 2218\u20132227 (2011).","journal-title":"Gastroenterology"},{"key":"BFnature17988_CR23","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrc3256","volume":"12","author":"AC Belkina","year":"2012","unstructured":"Belkina, A. C. & Denis, G. V. BET domain co-regulators in obesity, inflammation and cancer. Nature Rev. Cancer 12, 465\u2013477 (2012).","journal-title":"Nature Rev. Cancer"},{"key":"BFnature17988_CR24","first-page":"289","volume":"32","author":"I Cleynen","year":"2008","unstructured":"Cleynen, I. & Van de Ven, W. J. The HMGA proteins: a myriad of functions (review). Int. J. Oncol. 32, 289\u2013305 (2008).","journal-title":"Int. J. Oncol."},{"key":"BFnature17988_CR25","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1089\/nat.2013.0443","volume":"23","author":"G Hung","year":"2013","unstructured":"Hung, G. et al. Characterization of target mRNA reduction through in situ RNA hybridization in multiple organ systems following systemic antisense treatment in animals. Nucleic Acid Ther. 23, 369\u2013378 (2013).","journal-title":"Nucleic Acid Ther."},{"key":"BFnature17988_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1021\/jm801294h","volume":"52","author":"PP Seth","year":"2009","unstructured":"Seth, P. P. et al. Short antisense oligonucleotides with novel 2\u2032-4\u2032 conformationaly restricted nucleoside analogues show improved potency without increased toxicity in animals. J. Med. Chem. 52, 10\u201313 (2009).","journal-title":"J. Med. Chem."},{"key":"BFnature17988_CR27","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s40256-014-0077-0","volume":"14","author":"N Li","year":"2014","unstructured":"Li, N., Li, Q., Tian, X. Q., Qian, H. Y. & Yang, Y. J. Mipomersen is a promising therapy in the management of hypercholesterolemia: a meta-analysis of randomized controlled trials. Am. J. Cardiovasc. Drugs 14, 367\u2013376 (2014).","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"BFnature17988_CR28","doi-asserted-by":"publisher","first-page":"314ra185","DOI":"10.1126\/scitranslmed.aac5272","volume":"7","author":"D Hong","year":"2015","unstructured":"Hong, D. et al. AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer. Sci. Transl. Med. 7, 314ra185 (2015).","journal-title":"Sci. Transl. Med."},{"key":"BFnature17988_CR29","first-page":"969","volume":"6","author":"RG Lee","year":"2013","unstructured":"Lee, R. G., Crosby, J., Baker, B. F., Graham, M. J. & Crooke, R. M. Antisense technology: an emerging platform for cardiovascular disease therapeutics. J. Cardiovasc. Transl. Res. 6, 969\u2013980 (2013).","journal-title":"Transl. Res."},{"key":"BFnature17988_CR30","doi-asserted-by":"publisher","first-page":"5765","DOI":"10.1158\/1078-0432.CCR-11-0859","volume":"17","author":"F Saad","year":"2011","unstructured":"Saad, F. et al. Randomized phase II trial of custirsen (OGX-011) in combination with docetaxel or mitoxantrone as second-line therapy in patients with metastatic castrate-resistant prostate cancer progressing after first-line docetaxel: CUOG trial P-06c. Clin. Cancer Res. 17, 5765\u20135773 (2011).","journal-title":"Clin. Cancer Res."},{"key":"BFnature17988_CR31","unstructured":"Koechlein, C.S. et al. High resolution imaging and computational analysis of hematopoietic cell dynamics in vivo. Nature Comm. (in the press)."},{"key":"BFnature17988_CR32","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1084\/jem.191.2.253","volume":"191","author":"J Domen","year":"2000","unstructured":"Domen, J., Cheshier, S. H. & Weissman, I. L. The role of apoptosis in the regulation of hematopoietic stem cells: overexpression of Bcl-2 increases both their number and repopulation potential. J. Exp. Med. 191, 253\u2013264 (2000).","journal-title":"J. Exp. Med."},{"key":"BFnature17988_CR33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1073\/pnas.0912589107","volume":"107","author":"M Rovira","year":"2010","unstructured":"Rovira, M. et al. Isolation and characterization of centroacinar\/terminal ductal progenitor cells in adult mouse pancreas. Proc. Natl Acad. Sci. USA 107, 75\u201380 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature17988_CR34","unstructured":"R Development Core Team. R: a language and environment for statistical computing (R Foundation for Statistical Computing, 2012)."},{"key":"BFnature17988_CR35","unstructured":"Wu, J. et al. gcrma: background adjustment using sequence information. R package version 2.37.0."},{"key":"BFnature17988_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1677\/jme.0.0330001","volume":"33","author":"R S\u00e1sik","year":"2004","unstructured":"S\u00e1sik, R., Woelk, C. H. & Corbeil, J. Microarray truths and consequences. J. Mol. Endocrinol. 33, 1\u20139 (2004).","journal-title":"J. Mol. Endocrinol."},{"key":"BFnature17988_CR37","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. B"},{"key":"BFnature17988_CR38","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1073\/pnas.091062498","volume":"98","author":"VG Tusher","year":"2001","unstructured":"Tusher, V. G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl Acad. Sci. USA 98, 5116\u20135121 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature17988_CR39","doi-asserted-by":"publisher","first-page":"R106","DOI":"10.1186\/gb-2010-11-10-r106","volume":"11","author":"S Anders","year":"2010","unstructured":"Anders, S. & Huber, W. Differential expression analysis for sequence count data. Genome Biol. 11, R106 (2010).","journal-title":"Genome Biol."},{"key":"BFnature17988_CR40","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"BFnature17988_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1214\/07-STS236","volume":"23","author":"B Efron","year":"2008","unstructured":"Efron, B. Microarrays, empirical Bayes and the two-groups model. Stat. Sci. 23, 1\u201322 (2008).","journal-title":"Stat. Sci."},{"key":"BFnature17988_CR42","first-page":"31","volume":"12","author":"I Lonnstedt","year":"2002","unstructured":"Lonnstedt, I. & Speed, T. Replicated microarray data. Stat. Sin. 12, 31\u201346 (2002).","journal-title":"Stat. Sin."},{"key":"BFnature17988_CR43","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha, V. K. et al. PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nature Genet. 34, 267\u2013273 (2003).","journal-title":"Nature Genet."},{"key":"BFnature17988_CR44","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/ng.2889","volume":"46","author":"B Zimdahl","year":"2014","unstructured":"Zimdahl, B. et al. Lis1 regulates asymmetric division in hematopoietic stem cells and in leukemia. Nature Genet. 46, 245\u2013252 (2014).","journal-title":"Nature Genet."},{"key":"BFnature17988_CR45","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature07488","volume":"456","author":"DD Licatalosi","year":"2008","unstructured":"Licatalosi, D. D. et al. HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature 456, 464\u2013469 (2008).","journal-title":"Nature"},{"key":"BFnature17988_CR46","doi-asserted-by":"publisher","first-page":"3218","DOI":"10.1093\/nar\/gkr1139","volume":"40","author":"T Ohyama","year":"2012","unstructured":"Ohyama, T. et al. Structure of Musashi1 in a complex with target RNA: the role of aromatic stacking interactions. Nucleic Acids Res. 40, 3218\u20133231 (2012).","journal-title":"Nucleic Acids Res."},{"key":"BFnature17988_CR47","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1038\/mt.2011.201","volume":"19","author":"JB Carroll","year":"2011","unstructured":"Carroll, J. B. et al. Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene \/ allele-specific silencing of mutant huntingtin. Mol. Ther. 19, 2178\u20132185 (2011).","journal-title":"Mol. Ther."},{"key":"BFnature17988_CR48","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.2337\/db05-0705","volume":"55","author":"VT Samuel","year":"2006","unstructured":"Samuel, V. T. et al. Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action. Diabetes 55, 2042\u20132050 (2006).","journal-title":"Diabetes"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature17988.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature17988","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature17988.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T06:04:11Z","timestamp":1718604251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature17988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":48,"journal-issue":{"issue":"7607","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["BFnature17988"],"URL":"https:\/\/doi.org\/10.1038\/nature17988","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"15 September 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.I. and T.R. are named inventors on a patent application number 61\/178,370 titled \u2018Diagnostic and treatment for chronic and acute myeloid leukemia\u2019. Y.K. and A.R.M. are employees and shareholders of Ionis Pharmaceuticals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}